Rheumatoid Arthritis by the Guidelines: Best Practices in Treatment Selection and Disease Monitoring
Program Overview
The American College of Rheumatology recommends early intervention and treating to a target of remission or low disease activity when possible, and tight control of disease activity requires frequent disease monitoring and adjustment of therapy. Furthermore, with increasing patient engagement requirements, implementing shared decision-making strategies is critical to improve clinical outcomes. This activity addresses these issues with 2 brief patient scenarios that will challenge your decision making and provide benchmarking against other rheumatology clinicians.
The target audience for this activity is physicians, nurse practitioners, and physician assistants who specialize in rheumatology and internal medicine.
Educational Objectives
Upon completion of this activity, participants should be better able to:
Incorporate guideline-recommended disease activity measures into clinical practice
Select individualized treatments for patients with rheumatoid arthritis (RA) that maximize the opportunity to achieve remission and avoid relapse while minimizing toxicity
Employ a strong patient-provider collaborative approach to managing patients with RA that includes patient education, engagement, and shared decision making
Activity Faculty
Jeffrey R. Curtis, MD, MS, MPH
William J. Koopman Endowed Professor, Rheumatology and Immunology Director, UAB Arthritis Clinical Intervention Program Co-Director, UAB Center for Education and Research on Therapeutics
(CERTS) of Musculoskeletal Disorders Co-Director, UAB PharmacoEpidEmiology and phaRmcoeconomics (PEER) Unit
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
Birmingham, AL
Martin Jan Bergman, MD, FACR, FACP, FCPP
Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA
Iris Navarro-Millán MD, MSPH
Assistant Professor
Division of General Internal Medicine
Hospital for Special Surgery
Division of Rheumatology
Weill Cornell Medicine
New York, NY